Latest — Compound Chronicle

Independent commentary on peptide and research-compound science — drawn from the literature, the lab, and the researchers working with these compounds.

Latest2 items

Single paper · Aug 22, 2026

Retatrutide and Cardiovascular Risk Biomarkers: What the Latest Data Shows

A new analysis in Diabetes, Obesity & Metabolism reports improvements across cardiovascular risk biomarkers in adults with obesity on retatrutide — with and without type 2 diabetes.

Single paper · Aug 20, 2026

GLP-1 Receptor Agonists and Idiopathic Intracranial Hypertension: A Systematic Review

A systematic review examined GLP-1 receptor agonists in idiopathic intracranial hypertension — a signal that incretin research is expanding beyond metabolic outcomes.